The SCCS Scientific Advice on the Safety of Nanomaterials in Cosmetics
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Bernauer, UlrikeBodin, Laurent
Chaudhry, Qasim
Coenraads, Pieter J.
Dusinska, Maria
Gaffet, Eric
Panteri, Eirini
Rogiers, Vera
Rousselle, Christophe
Stepnik, Maciej
Vanhaecke, Tamara
Wijnhoven, Susan
von Goetz, Natalie
de Jong, Wim H.
Affiliation
Federal Institute for Risk Assessment, Berlin; Alternative Energies and Atomic Energy Commission, France; University of Chester; University Medical Center Groningen; Norwegian Institute for Air Research; Université de Lorraine; National and Kapodistrian University of Athens; Vrije Universiteit, Brussels; French Agency for Food, Environmental and Occupational Health & Safety; Qsar Lab, Gdańsk; National Institute for Public Health and the Environment, Bilthoven; Federal Office of Public Health, Switzerland; National Institute for Public Health, BilthovenPublication Date
2021-09-22
Metadata
Show full item recordAbstract
The Cosmetic Regulation (EC) No 1223/2009 specifically covers the risk of nanomaterials used in cosmetic products. If there are concerns regarding the safety of a nanomaterial, the European Commission refers it to the SCCS for a scientific opinion. The Commission mandated the SCCS to identify the scientific basis for safety concerns that could be used as a basis for identifying and prioritising nanomaterials for safety assessment, and to revisit previous inconclusive SCCS opinions on nanomaterials to identify any concerns for potential risks to the consumer health. The SCCS Scientific Advice identified the key general aspects of nanomaterials that should raise a safety concern for a safety assessor/manager, so that the nanomaterial(s) in question could be subjected to safety assessment to establish safety to the consumer. The Advice also developed a list of the nanomaterials notified to the Commission for use in cosmetics in an order of priority for safety assessment, and revisited three previous inconclusive opinions on nanomaterials to highlight concerns over consumer safety that merited further safety assessment.Citation
Bernauer, U., Bodin, L., Chaudhry, Q., Coenraads, P. J., Dusinska, M., Gaffet, E., Panteri, E., Rogiers, V., Rousselle, C., Stepnik, M., Vanhaecke, T., Wijnhoven, S., von Goetz, N., & de Jong, W. H. (2021). The SCCS scientific advice on the safety of nanomaterials in cosmetics. Regulatory Toxicology and Pharmacology, 126, 105046. https://doi.org/10.1016/j.yrtph.2021.105046Publisher
ElsevierType
ArticleDescription
This article is not available on ChesterRepISSN
0273-2300ae974a485f413a2113503eed53cd6c53
10.1016/j.yrtph.2021.105046